The incidence of coronary artery disease among patients with severe aortic stenosis and candidates for TAVI ranges from 40 to 75%. In the absence of randomized trials, the management of these patients remains to be established. In this paper, the authors offer a good overview of the subject and propose an algorithm for treatment.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Aortic valve disease
June 26, 2014
In this study the authors use data from 1432 patients included in the German TAVI registry to identify variables which predict poor outcome in patients left with more than mild aortic regurgitation (AR) following TAVI. The Medtronic Core Valve prosthesis had been used in the great majority of the procedures.
June 20, 2014
This single-centre propensity matched study aimed to compare the outcomes between patients undergoing transapical TAVI or surgical aortic valve replacement in patients who have previously undergone cardiac surgery. Patients who underwent procedures between 2005 and 2012 were included with 40 patients in each group following propensity matching.
June 9, 2014
A step-by-step guide for performing an aortic root replacement with the Freestyle Aortic Root. Safeguards and pitfalls are reviewed.
June 3, 2014
The authors of this paper prospectively studied stroke after aortic valve replacement (AVR) in patients with aortic stenosis (AS) and >65years old. Neurological status was assessed pre- and postoperatively assessed by neurologists, postoperatively by MRI and strokes were evaluated according to the National Institutes of Health Stroke Sscale.
June 1, 2014
This multi-centre registry study assessed peri-operative and long-term outcomes in patients who underwent isolated surgical aortic valve replacement (AVR) who had previous undergone coronary artery bypass graft surgery (CABG). The study included 113 patients who underwent AVR after previous CABG across seven centres between 2000-2013.
May 22, 2014
Traditionally, patients undergoing TAVI are treated with dual antiplatelet therapy (DAPT). This strategy in not based on strong evidence.
May 21, 2014
The PORTICO trial has opened to evaluate the Portico Transcatheter Aortic Valve System. This prospective multicenter trial involving up to 40 sites will randomize pts to Portico vs another TAVR valve in the US.
May 21, 2014
This expert review identifies knowledge gaps with regards to valvulopathy and aortopathy associated with bicuspid valves and proposes strategies for improving knowledge.
May 9, 2014
The FRANCE 2 investigators have developed a scoring system to predict the risk of in-hospital or 30-day mortality for patients undergoing TAVI. There were 3833 TAVIs used for development and validation of the scoring system with the majority of patients receiving an Edwards Sapien prosthesis.